Search Results

Displaying Results 526-550 of 940 "'PI'"

Feb 02, 2026, 22:08 ET 寶理塑料開發出含機械回收料的新型DURAFIDE(R) PPS規格產品

1140A1R00與1140A1R30(分別採用100%和30%回收玻璃纖維增強PPS材料)——預計將在未來幾個月內正式推出。 圖片:https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202601202736/_prw_PI1fl_5M5BC94J.jpg這些新產品是寶理塑料DURACIRCLE(R)計劃的組成

More news about: Polyplastics Co., Ltd.


Feb 02, 2026, 21:12 ET Polyplastics desarrolla nuevos grados de PPS DURAFIDE(R) con contenido reciclado mecánicamente

https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202601202736/_prw_PI1fl_5M5BC94J.jpgLa nueva oferta es parte de la iniciativa DURACIRCLE(R) de Polyplastics, que se esfuerza por lograr

More news about: Polyplastics Co., Ltd.


Feb 02, 2026, 21:08 ET Polyplastics entwickelt neue DURAFIDE(R)-PPS-Typen mit Anteil an mechanisch recyceltem Material

https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202601202736/_prw_PI1fl_5M5BC94J.jpgDas neue Angebot ist Teil der DURACIRCLE(R)-Initiative von Polyplastics, die darauf abzielt, für

More news about: Polyplastics Co., Ltd.


Feb 02, 2026, 09:00 ET Future of Legal Tech 2026 Report Finds AI Adoption in Personal Injury Firms Has Shifted from Experimentation to Execution

matter more than new features."Key Findings from the Future of Legal Tech 2026 Report:More than 50% of PI firms are already using AI, signaling mainstream adoption78% expect AI to improve efficiency and productivity, reinforcing its operational

More news about: LawPro.ai Inc.


Feb 01, 2026, 20:50 ET ROHMs neue LDO-Regler mit 500 mA Ausgangsstrom sorgen selbst mit ultrakleinen Kondensatoren für stabilen Betrieb

https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202601202706/_prw_PI1fl_0F05utFG.jpgIn den vergangenen Jahren wird bei elektronischen Geräten eine höhere Packungsdichte bei gleichzeitig

More news about: ROHM Co., Ltd.


Jan 30, 2026, 08:00 ET Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)

Suppressed aggressive mesenchymal phenotype and metastasis-associated gene programs (including VIM, ZEB1, FN1);Reduced oncogenic PI3K/AKT and MAPK signalling;Increased intratumoral CD8+ cytotoxic T-cell infiltration and Granzyme B expression; andReduced

More news about: Kazia Therapeutics Limited


Jan 30, 2026, 01:00 ET Keio Plaza Hotel Tokyo Hosts "25th Hinamatsuri Doll Festival Celebration," Featuring Magnificent 5,000 Hanging Art Ornaments and Beautiful Folding Screen Displays

https://cdn.kyodonewsprwire.jp/prwfile/release/M000115/202601263010/_prw_PI1fl_Wahr5azw.jpg Special website: https://www.keioplaza.com/offers/hina2026.html The

More news about: Keio Plaza Hotel Co., Ltd.


Jan 29, 2026, 11:11 ET Arasan anuncia la disponibilidad inmediata de la primera IP física combinada xSPI NOR + eMMC NAND del sector

29 de enero de 2026 /PRNewswire/ -- Arasan Chip Systems, proveedor líder de propiedad intelectual (PI) de semiconductores para SoC móviles y de automóviles, anunció hoy la disponibilidad inmediata de su IP xSPI + eMMC Combo PHY. Esta IP integra xSPI y

More news about: Arasan Chip Systems, Inc.


Jan 29, 2026, 10:06 ET Sprout Pharmaceuticals' Addyi® (flibanserin) Named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards

mouth.See Full Prescribing Information and Medication Guide, including Boxed Warning regarding hypotension and syncope in certain settings at Addyi.com/pi. SOURCE: Sprout Pharmaceuticals* IQVIA Monthly Total Prescriptions Volume Data Comparing Addyi vs Vyleesi in the US. Sept 2022–Dec

More news about: Sprout Pharmaceuticals


Jan 29, 2026, 07:00 ET I-care Joins AVEVA Partner Ecosystem as a Managed Solution Provider, and Integrates AVEVA™ PI System™ Data into Its Analytics Platform

integration, I-care enables customers to leverage operational data from the AVEVA PI System to support predictive maintenance, asset health monitoring, and reliability use cases across industrial environments.The AVEVA PI System is widely used by industrial organizations to collect, contextualize,

More news about: I-care


Jan 28, 2026, 20:42 ET 日本環球影城將為粉絲打造沉浸式寶可夢體驗

LLC運營的日本環球影城與寶可夢公司宣布,雙方計劃推出更具創新性、沉浸感且世界一流的寶可夢體驗。該項目是日本環球影城持續提升園區內容、引進以粉絲為先、能吸引游客到訪的經典角色計劃的一部分。 圖片:https://cdn.kyodonewsprwire.jp/prwfile/release/M108172/202601212812/_prw_PI3fl_SEE5eL7J.jpg日本環球影城將基於其以往的成功經驗,首次以嶄新且多元化的方式生動呈現寶可夢世界。在日本首發後,Universal

More news about: USJ LLC


Jan 28, 2026, 00:00 ET Polyplastics Develops New DURAFIDE(R) PPS Grades with Mechanically Recycled Content

https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202601202736/_prw_PI1fl_5M5BC94J.jpgThe new offering is part of Polyplastics' DURACIRCLE(R) initiative, which strives to achieve 100%

More news about: Polyplastics Co., Ltd.


Jan 28, 2026, 00:00 ET Polyplastics Develops New DURAFIDE(R) PPS Grades with Mechanically Recycled Content

https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202601202736/_prw_PI1fl_5M5BC94J.jpgThe new offering is part of Polyplastics' DURACIRCLE(R) initiative, which strives to achieve 100%

More news about: Polyplastics Co., Ltd.


Jan 27, 2026, 15:49 ET DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

prior therapy As monotherapy in patients who have received at least three prior lines of therapy including a PI and an immunomodulatory agent or who are double refractory to a PI and an immunomodulatory agent DARZALEX FASPRO® as monotherapy is indicated for the treatment

More news about: Johnson & Johnson


Jan 27, 2026, 10:15 ET PlanetiQ's Radio Occultation Data Rated "Best-in-Class" by NASA CSDA

Signal-to-Noise Ratio (SNR), ionosphere calibrated carrier phase and SNR for scintillations, and ionosphere total electron count. Nine competitively selected PI-led teams from a range of government, academic, and commercial researchers reviewed the data. Overall, most of the evaluators found that PlanetiQ's data

More news about: PlanetiQ


Jan 27, 2026, 08:00 ET Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

cancer populations, including earlier-stage TNBC and hormone receptor–positive, HER2-negative (HR+ / HER2-) breast cancer, where dysregulation of the PI3K/mTOR pathway is well established. Paxalisib's oral, once-daily administration offers a potentially convenient treatment option with minimal incremental

More news about: Kazia Therapeutics Limited


Jan 27, 2026, 02:00 ET ROHM's New LDO Regulators with 500mA Output Current Achieve Stable Operation Even with Ultra-small Capacitors

https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202601202706/_prw_PI1fl_0F05utFG.jpgIn recent years, electronic devices have demanded higher density in smaller form factors at the same

More news about: ROHM Co., Ltd.


Jan 27, 2026, 02:00 ET ROHM's New LDO Regulators with 500mA Output Current Achieve Stable Operation Even with Ultra-small Capacitors

https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202601202706/_prw_PI1fl_0F05utFG.jpgIn recent years, electronic devices have demanded higher density in smaller form factors at the same

More news about: ROHM Co., Ltd.


Jan 26, 2026, 21:04 ET Anuncio de los galardonados con el Premio Japón 2026

https://cdn.kyodonewsprwire.jp/prwfile/release/M000319/202601142440/_prw_PI1fl_4D06A8QY.jpg - Campo elegible para el premio: ciencias de la vidaImagen del Prof. Shizuo Akira: 

More news about: Japan Prize Foundation


Jan 26, 2026, 20:50 ET Laureados do Japan Prize 2026 são anunciados

https://cdn.kyodonewsprwire.jp/prwfile/release/M000319/202601142440/_prw_PI1fl_4D06A8QY.jpg - Área elegível para o prêmio: Ciências da VidaImagem do professor Shizuo Akira:

More news about: Japan Prize Foundation


Jan 26, 2026, 20:46 ET Preisträger des Japan-Preises 2026 bekannt gegeben

https://cdn.kyodonewsprwire.jp/prwfile/release/M000319/202601142440/_prw_PI1fl_4D06A8QY.jpg - Für den Preis in Frage kommender Bereich: BiowissenschaftenBild von Prof. Shizuo Akira:

More news about: Japan Prize Foundation


Jan 26, 2026, 19:00 ET Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma

myeloma, (R/R MM) in patients who have received four or more lines of previous anti-myeloma therapies, that include at least a proteasome inhibitor (PI), an immunomodulatory drug (IMiD), and an anti-CD38 monoclonal antibody. IBI3003 was discovered and developed using Innovent's proprietary Sanbody®

More news about: Innovent Biologics


Jan 26, 2026, 10:07 ET Nord Anglia Awards US$249,000 to Student-Led Community Initiatives Strengthened by Metacognitive Learning

Hearthstone, an assistive–technology programme designed to support individuals who are hard of hearing or non–verbal. Using small, affordable Raspberry Pi computers, they are developing a system that converts American Sign Language hand movements and facial expressions into spoken audio.Lord

More news about: Nord Anglia Education


Jan 26, 2026, 08:37 ET StockHero Launches Version 4 as Automated Trading Accelerates Among Retail Investors

Intelligence CapabilitiesVersion 4 introduces the Pi Models, a new family of AI-driven strategies created to support varying risk profiles, from conservative to high-volatility trading. Pi2 and Pi3 will be available at launch, with Pi4 planned for a future release. These AI models reflect a

More news about: StockHero


Jan 23, 2026, 04:41 ET Se anuncian los ganadores del Premio Japón 2026

https://cdn.kyodonewsprwire.jp/prwfile/release/M000319/202601142440/_prw_PI1fl_4D06A8QY.jpg - Campo de estudio del premio: Ciencias de la vidaImagen del profesor Shizuo Akira: 

More news about: Japan Prize Foundation


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.